Prot #VX16-152-102: A Phase 2, Randomized, Double-blind, Controlled Study to Evaluate the Safety of VX-152 Combination Therapy in Adults With Cystic Fibrosis

Project: Research project

StatusActive
Effective start/end date11/1/1611/1/19

Funding

  • Covance Inc. (Prot #VX16-152-102)
  • Vertex Pharmaceuticals Incorporated (Prot #VX16-152-102)